FrancophonIA/ELRC3.0 huggingface dataset:
English: All patients treated with Palynziq developed a sustained total anti-pegvaliase antibody (TAb) response with a majority of patients (91%) becoming positive by Week 4.
Croatian: Svi bolesnici liječeni lijekom Palynziq razvili su održani ukupni odgovor protutijelima na pegvaliazu (engl. total antibody, TAb) s većinom bolesnika (91%) pozitivnom do 4. tjedna.
English: At baseline, 149 (57%) patients were receiving part of their total protein intake from medical food and 41 out of 261 (16%) patients were on a phenylalanine-restricted diet (defined as receiving greater than 75% of total protein intake from medical food).
Croatian: Na početku liječenja, 149 (57%) bolesnika primalo je dio ukupnog unosa proteina medicinskom prehranom, a od 261 bolesnika 41 (16%) bolesnik bio je na dijeti s ograničenim unosom fenilalanina (definirano kao dobivanje više od 75% ukupnog unosa proteina iz medicinske prehrane).
English: Of the 5 serum sickness episodes where time to onset was evaluable, 1 episode occurred within 1 hour of injection and 4 episodes occurred between 24 hours and up to 5 days following injection.
Croatian: Od 5 epizoda serumske bolesti gdje je vrijeme do pojave bilo moguće procijeniti, 1 epizoda javila se unutar 1 sata od injekcije, dok su se 4 epizode javile između 24 sata i 5 dana nakon injekcije.
English: Step 14: Slowly move your thumb up to release the plunger allowing the needle to automatically be covered by the syringe body (see Figure N).
Croatian: Korak 14: Polako pomičite palac kako biste oslobodili klip omogućavajući tako da tijelo štrcaljke automatski prekrije i (pogledajte Sliku N).
English: 3 Post-baseline ADHD-inattention/PKU-POMS confusion values were mapped to the closest 3-month visit (i.e. within a 3-month window).
Croatian: Vrijednosti ocjene ADHD-nepažnje/PKU-POMS konfuzije nakon početne vrijednosti mapirane su na najbliži 3-mjesečni posjet (tj. unutar 3 mjeseca).
English: 2 Additional time may be required prior to each dose escalation based on patient tolerability with Palynziq.
Croatian: 2 Dodatno vrijeme može biti potrebno prije svakog povećanja doze na temelju bolesnikove podnošljivosti lijeka Palynziq.
English: Study 302 was a follow-on study (from Study 301) and included: an open label eligibility period; a double-blind, placebo-controlled randomised discontinuation trial period (RDT), and a long-term open-label extension period.
Croatian: Ispitivanje 302 bilo je nastavak ispitivanja (Ispitivanja 301) i uključivalo je: otvoreno razdoblje podobnosti; dvostruko slijepo, placebom kontrolirano razdoblje ispitivanja s randomiziranim prekidom primjene lijeka (engl. randomised discontinuation trial, RDT) i otvoreno razdoblje dugotrajnog nastavka ispitivanja.
English: Once blood phenylalanine levels less than 600 micromol/l on stable dose was reached, patients were considered to be in the maintenance phase thereafter.
Croatian: Nakon što se postigla razina fenilalanina u krvi niža od 600 mikromola/l na stabilnoj dozi, smatralo se da su bolesnici prešli u fazu održavanja.
English: Pegvaliase plasma exposure was primarily driven by immune response to pegvaliase.
Croatian: Izloženost pegvaliazi u plazmi prvenstveno je ovisila o imunološkom odgovoru na pegvaliazu.
English: Injection of other medicines that contain PEG while using Palynziq Palynziq includes an ingredient called polyethylene glycol (PEG).
Croatian: Primjena injekcija drugih lijekova koji sadrže PEG tijekom primjene lijeka Palynziq Palynziq sadrži sastojak koji se zove polietilenglikol (PEG).
English: Following cellular uptake, the metabolism of phenylalanine ammonia lyase (PAL) is expected to occur via catabolic pathways and be degraded into small peptides and amino acids; the PEG molecule is metabolically stable and expected to be separated from PAL protein and primarily eliminated by renal filtration.
Croatian: Nakon staničnog unosa, očekuje se da će se fenilalanin-amonij-lijaza (PAL) metabolizirati kataboličkim putovima i razgraditi na male peptide i aminokiseline; PEG molekula je metabolički stabilna i očekuje se da će biti odvojena od PAL proteina i primarno eliminirana bubrežnom filtracijom.
English: If you use more Palynziq than you should
Croatian: Ako primijenite više lijeka Palynziq nego što ste trebali
English: • The patient information pack should contain: o The patient information leaflet o The guide for patients and trained observers o The patient alert card
Croatian: • Informativni paket za bolesnike treba sadržavati: o Uputu o lijeku o Vodič za bolesnike i obučene promatrače o Karticu upozorenja za bolesnika
English: Monitoring of blood phenylalanine level is recommended once a month.
Croatian: Preporučuje se praćenje razine fenilalanina u krvi jednom mjesečno.
English: Table 4: Efficacy results at Month 12, Month 18, Month 24 and Month 36 in Palynziq-treated patients Baseline Month 12 Month 18 Month 24 Month 36
Croatian: Tablica 4: Rezultati djelotvornosti u bolesnika liječenih lijekom Palynziq u 12. mjesecu, 18. mjesecu, 24. mjesecu i 36. mjesecu
English: A total of 164 previously-treated Palynziq patients (152 patients from Study 301, and 12 patients from other Palynziq trials) continued treatment for up to 13 weeks.
Croatian: Ukupno 164 bolesnika prethodno liječena lijekom Palynziq (152 bolesnika iz Ispitivanja 301 i 12 bolesnika iz drugih ispitivanja lijeka Palynziq) nastavilo je liječenje do 13 tjedana.
English: Randomised discontinuation trial (RDT) period
Croatian: Razdoblje ispitivanja s randomiziranim prekidom primjene lijeka (RDT)
English: 4 Abdominal pain reflects the following terms: abdominal pain, abdominal pain upper and abdominal discomfort.
Croatian: 4 Pojam abdominalna bol odnosi se na sljedeće pojmove: bol u abdomenu, bol u gornjem dijelu abdomena i nelagodu u abdomenu.
English: Reactions were managed by administration of adrenaline (10/16 patients; 11/25 episodes), corticosteroids, antihistamines, and/or oxygen under emergency medical care.
Croatian: Reakcije su liječene primjenom adrenalina (10/16 bolesnika, 11/25 epizoda), kortikosteroida, antihistaminika i/ili kisika pod hitnom medicinskom skrbi.
English: Pegvaliase induced anti-PEG IgM and IgG responses were detected in the majority of patients (98%) and titres peaked at 1 to 3 months after treatment initiation and then returned to baseline levels in most patients by 6 to 9 months after treatment initiation (see section 4.5).
Croatian: Anti-PEG IgM i IgG odgovori inducirani pegvaliazom zabilježeni su u većine bolesnika (98%), vrijednost titara bila je najveća od 1 do 3 mjeseca nakon početka liječenja, a potom se u većine bolesnika vratila na početnu vrijednost unutar 6 do 9 mjeseci nakon početka liječenja (vidjeti dio 4.5).
English: If you stop taking Palynziq treatment, your blood phenylalanine levels are likely to increase.
Croatian: Ako prestanete primjenjivati lijek Palynziq, vjerojatno će Vam se razina fenilalanina u krvi povisiti.
English: Talk to your healthcare provider about the best way to feed your baby if you use Palynziq.
Croatian: Razgovarajte sa svojim liječnikom o najboljem načinu na koji hraniti svoje dijete ako primjenjujete lijek Palynziq.
English: There are no or limited amount of data from the use of Palynziq in pregnant women.
Croatian: Nema podataka ili su podaci o primjeni lijeka Palynziq u trudnica ograničeni.
English: This person must stay with you for at least 1 hour after your injection to watch you for signs and symptoms of a severe allergic reaction and, if needed, give you an injection of adrenaline and call for emergency medical help.
Croatian: Ta osoba mora ostati uz Vas najmanje jedan sat nakon primjene injekcije i pratiti zbog moguće pojave znakova i simptoma teške alergijske reakcije te Vam, ako je potrebno, dati injekciju adrenalina i pozvati hitnu medicinsku službu.
English: Immune response affects clearance and time to reach steady state.
Croatian: Imunološki odgovor utječe na klirens i vrijeme do postizanja stanja dinamičke ravnoteže.
English: Talk to your healthcare provider if you have any questions about how to inject Palynziq the right way.
Croatian: Razgovarajte sa svojim liječnikom ako imate pitanja o tome kako pravilno injicirati lijek Palynziq.
English: Mean (SD) for apparent volume of distribution (Vz/F) at steady state following 20 mg and 40 mg doses was 26.4 L (64.8 L) and 22.2 L (19.7 L) respectively.
Croatian: Srednja vrijednost (standardna devijacija) za prividni volumen distribucije (Vz/F) u stanju dinamičke ravnoteže nakon doza od 20 mg i 40 mg bila je 26,4 l (64,8 l) odnosno 22,2 l (19,7 l).
English: • Your doctor will also prescribe adrenaline injection device to use for any severe allergic reactions.
Croatian: • Vaš liječnik će Vam također propisati uređaj za injekciju adrenalina za primjenu kod bilo kakvih teških alergijskih reakcija.
English: • If you need more than 1 injection for your daily dose, the injection sites should be at least 5 centimetres away from each other (see Figures E and F).
Croatian: • Ako Vam je za dnevnu dozu potrebno više od jedne injekcije, mjesta injiciranja trebaju biti međusobno udaljena najmanje 5 centimetara (pogledajte slike E i F).
English: Palynziq is not recommended during pregnancy, unless the clinical condition of the woman requires treatment with pegvaliase and alternative strategies to control phenylalanine levels have been exhausted.
Croatian: Palynziq se ne preporučuje tijekom trudnoće, osim ako je za kliničko stanje žene potrebno liječenje pegvaliazom, a druge strategije za kontrolu razine fenilalanina su iscrpljene.
English: Time needed to lower your blood phenylalanine levels Your doctor will start you on Palynziq at a low dose and will increase your dose slowly.
Croatian: Vrijeme potrebno za snižavanje razina fenilalanina u krvi Liječnik će Vam početi primjenjivati lijek Palynziq u malim dozama te će doze polako povećavati.
English: Of the 9 angioedema episodes where time to onset was evaluable, 5 episodes occurred within 24 hours of injection, 4 episodes occurred between 24 hours and up to 29 days of injection.
Croatian: Od 9 epizoda angioedema gdje je vrijeme do pojave bilo moguće procijeniti, 5 epizoda javilo se unutar 24 sata od injekcije, dok su se 4 epizode javile između 24 sata i 29 dana od injekcije.
English: Patients in the 20 mg once daily randomised arm reached their maintenance dose at a median time of 10 weeks (range: 9 to 29 weeks) and patients in the 40 mg once daily arm reached their maintenance dose at a median time of 11 weeks (range: 10 to 33 weeks).
Croatian: Bolesnici u randomiziranoj skupini koja je primala 20 mg jedanput dnevno postigli su svoju dozu održavanja u medijanu vremena od 10 tjedana (raspon: 9 do 29 tjedana), a bolesnici u skupini koja je primala 40 mg jednom dnevno postigli su svoju dozu održavanja u medijanu vremena od 11 tjedana (raspon: 10 do 33 tjedna).
English: Effect of Palynziq on other PEGylated injectable medicinal products
Croatian: Učinak lijeka Palynziq na druge pegilirane injekcijske lijekove
English: • Your doctor will prescribe medicines for you to take before your Palynziq injection, such as paracetamol, fexofenadine, and/or ranitidine.
Croatian: • Liječnik će Vam propisati lijek koji je potrebno uzimati prije injekcije lijeka Palynziq, poput paracetamola, feksofenadina i/ili ranitidina.
English: Phenylalanine levels over time
Croatian: Razine fenilalanina tijekom vremena
English: The effects of Palynziq in the treatment of PKU have been demonstrated in patients with phenylketonuria in Study 301, an open-label study to initiate Palynziq treatment, and Study 302, a follow-on study for efficacy assessment.
Croatian: Učinci lijeka Palynziq u liječenju PKU dokazani su u bolesnika s fenilketonurijom u Ispitivanju 301, otvorenom ispitivanju za pokretanje liječenja lijekom Palynziq i u Ispitivanju 302, nastavku ispitivanja za procjenu djelotvornosti.
English: The automatic needle guard is composed of a polycarbonate transparent needle guard and a stainless steel spring inside the needle guard.
Croatian: Automatski štitnik za iglu sastoji se od polikarbonatnog prozirnog štitnika za iglu i opruge od nehrđajućeg čelika unutar štitnika.
English: At high pegvaliase Ctrough concentrations ≥ 10,000 ng/ml, the majority of the blood phenylalanine levels (97%) are ≤ 30 micromol/l, even when dietary phenylalanine intake is high.
Croatian: Pri visokim Ctrough koncentracijama pegvaliaze (≥ 10 000 ng/ml), većina razina fenilalanina u krvi (97%) je ≤ 30 mikromola/l čak i kada je unos fenilalanina prehranom visok.
English: Treatment with Palynziq should be directed by physicians experienced in the management of PKU.
Croatian: Liječenje lijekom Palynziq treba voditi liječnik s iskustvom u liječenju PKU.
English: You may see a drop of liquid on the tip of the needle.
Croatian: Na vrhu igle možete vidjeti kapljicu tekućine.
English: • You will start Palynziq at the lowest dose.
Croatian: • Liječenje lijekom Palynziq ćete započeti najmanjom dozom.
English: Eighteen out of 21 patients who experience angioedema were re-challenged and 5 patients had at least one recurrence.
Croatian: Od 21 bolesnika kod kojeg se pojavio angioedem, 18 je ponovno primilo lijek, a 5 bolesnika imalo je najmanje jedan povrat reakcije.
English: • Do not remove the needle cap until you are ready to inject Palynziq.
Croatian: • Nemojte skidati kapicu igle dok niste spremni injicirati lijek Palynziq.
English: Acute systemic hypersensitivity reactions
Croatian: Akutne sistemske reakcije preosjetljivosti
English: • 54% of patients, 69% of patients, and 72% of patients reached blood phenylalanine level
Croatian: • 54% bolesnika, 69% bolesnika i 72% bolesnika postiglo je koncentraciju fenilalanina u krvi
English: • This medicine comes in pre-filled syringes with 3 different strengths (2.5 mg-white plunger, 10 mg-green plunger, or 20 mg-blue plunger).
Croatian: • Ovaj se lijek isporučuje u napunjenim štrcaljkama u 3 različite jačine (2,5 mg-bijeli klip, 10 mg-zeleni klip ili 20 mg-plavi klip).
English: These findings occurred in the presence of maternal toxicity (decreased body weights, decreased ovarian weights, and decreased food consumption) and were associated with markedly decreased maternal blood phenylalanine below normal levels in non-PKU animals.
Croatian: Ta su se zapažanja javila u prisutnosti toksičnosti majke (smanjena tjelesna težina, smanjena težina jajnika i smanjeno uzimanje hrane) i bila su povezana s primjetnim smanjenjem razina fenilalanina u krvi majke ispod normalnih razina za životinje bez PKU.
English: Important things to know about using your Palynziq pre-filled syringe:
Croatian: Važne stvari koje trebate znati o primjeni napunjene štrcaljke lijeka Palynziq:
English: • Do not hold the pre-filled syringe by the plunger or plunger head while taking the needle cap off.
Croatian: • Nemojte držati napunjenu štrcaljku za klip ili glavu klipa dok skidate kapicu igle.
English: If hypophenylalaninaemia develops once daily dosing is reached, the dose may be reduced by at least 10 mg decrements to achieve and maintain blood phenylalanine levels in the clinically acceptable range.
Croatian: Ako se hipofenilalaninemija javi nakon postizanja dnevnog doziranja, doza se može smanjivati po najmanje 10 mg za postizanje i održavanje razine fenilalanina u krvi u klinički prihvatljivom rasponu.
English: If a caregiver is giving the injection, the top of the buttocks and the back of the upper arms may also be used (see Figure E).
Croatian: Ako injekciju daje njegovatelj, lijek se također može primijeniti u gornji dio stražnjice i u vanjski dio nadlaktice (pogledajte Sliku E).
English: Put your used needles and syringes in a sharps disposal or puncture-resistant container right away after use.
Croatian: Odložite upotrijebljene igle i štrcaljke u neprobojan spremnik za odlaganje oštrih predmeta odmah nakon svake primjene.
English: Patients should be monitored every 2 weeks until blood phenylalanine levels are within a clinically acceptable range (see section 4.4, Hypophenylalaninaemia).
Croatian: Bolesnike je potrebno pratiti svaka 2 tjedna dok razina fenilalanina u krvi ne bude unutar klinički prihvatljivog raspona (vidjeti dio 4.4, Hipofenilalaninemija).
English: Maternal blood phenylalanine levels must be strictly controlled between 120 and 360 micromol/l both before and during pregnancy.
Croatian: Razinu fenilalanina u krvi majke potrebno je strogo kontrolirati i održavati u rasponu od 120 do 360 mikromola/l prije i tijekom trudnoće.
English: You may cover the injection site with an adhesive bandage if needed.
Croatian: Ako je potrebno, mjesto injiciranja možete prekriti flasterom.
English: The most common injection site reactions (occurring in at least 10% of patients) were reaction, erythema, bruising, pruritus, pain, swelling, rash, induration, and urticaria.
Croatian: Najčešće reakcije na mjestu primjene injekcije (javile su se u najmanje 10% bolesnika) bile su reakcija, eritem, modrica, pruritus, bol, oticanje, osip, induracija i urtikarija.
English: 1 Post-baseline phenylalanine values were mapped to the closest monthly visit (i.e. within a 1-month window).
Croatian: 1 Vrijednosti fenilalanina nakon početne vrijednosti mapirane su na najbliži mjesečni posjet (tj. unutar jednog mjeseca).
English: • The physician educational material should contain: o The Summary of Product Characteristics o Guide for healthcare professionals
Croatian: • Obrazovni materijal za liječnike treba sadržavati: o Sažetak opisa svojstava lijeka o Vodič za zdravstvene radnike
English: Ten out of the 16 patients who experienced an acute systemic hypersensitivity reaction were rechallenged and 4 patients had at least one recurrence.
Croatian: Od 16 bolesnika koji su imali akutnu sistemsku reakciju preosjetljivosti, 10 je ponovno primilo lijek, a 4 bolesnika imala su najmanje jedan povrat reakcije.
English: Arthralgia episodes were managed with concomitant medicinal products (e.g., nonsteroidal anti-inflammatory drugs, glucocorticoids, and/or antipyretic), dose reduction (4% of episodes), treatment interruption (4% of episodes), or treatment withdrawal (0.6% of episodes), and 97% of arthralgia episodes resolved by the time of the data cut-off.
Croatian: Epizode artralgije liječene su popratnim lijekovima (npr. nesteroidnim protuupalnim lijekovima, glukokortikoidima i/ili antipireticima), smanjenjem doze (4% epizoda), privremenim prekidom liječenja (4% epizoda) ili trajnom obustavom liječenja (0,6% epizoda), a 97% epizoda artralgije povuklo se do prestanka prikupljanja podataka.
English: Palynziq is a treatment for patients aged 16 years and older with phenylketonuria (PKU), a rare inherited disorder that causes phenylalanine from proteins in food to build up in the body.
Croatian: Palynziq je lijek za bolesnike u dobi od 16 godina i starije s fenilketonurijom (PKU), rijetkim nasljednim poremećajem koji uzrokuje nagomilavanje u tijelu fenilalanina iz proteina u hrani.
English: After injection, the spring expands causing the needle to be covered by the needle guard.
Croatian: Nakon injiciranja, opruga se širi, što dovodi do pokrivanja igle štitnikom za iglu.
English: After injection, the needle automatically retracts into the needle guard safely covering the needle.
Croatian: Nakon injiciranja, igla štrcaljke automatski se uvlači u štitnik za iglu koji sigurno prekrije iglu.
English: Palynziq is not recommended during pregnancy unless your condition requires treatment with Palynziq and other ways of controlling your blood phenylalanine levels do not work.
Croatian: Palynziq se ne preporučuje tijekom trudnoće, osim ako je za Vaše stanje potrebno liječenje lijekom Palynziq, a drugi načini kontrole Vaše razine fenilalanina u krvi ne djeluju.
English: Patients initiated Palynziq treatment with an induction regimen (2.5 mg once week for 4 weeks) and were titrated in a stepwise manner (increased dose and frequency) to reach their randomised target dose of 20 mg once daily or 40 mg once daily.
Croatian: Bolesnici su započeli liječenje lijekom Palynziq režimom indukcije (2,5 mg jednom tjedno tijekom 4 tjedna) i titrirani su postupno (povećanje doze i učestalosti) kako bi dosegli randomiziranu ciljnu dozu od 20 mg jednom dnevno ili 40 mg jednom dnevno.
English: The maintenance dose is individualised to achieve patient's blood phenylalanine control (i.e., a phenylalanine level between 120 to 600 micromol/l) taking into account patient tolerability to Palynziq and dietary protein intake (see Table 1).
Croatian: Doza održavanja individualizirana je kako bi se postigla kontrola fenilalanina u krvi bolesnika (tj. razina fenilalanina od 120 do 600 mikromola/l) uzimajući u obzir podnošljivost lijeka Palynziq za bolesnika i unos proteina hranom (vidjeti Tablicu 1).
English: Of the 11 patients initially enrolled in Study 301, 3 patients reached blood phenylalanine levels ≤ 600 micromol/l by 12 months, 7 patients reached this threshold by 24 months, and 8 patients reached this threshold by 36 months.
Croatian: Od 11 bolesnika prvotno uključenih u Ispitivanje 301, 3 bolesnika postigla su razine fenilalanina u krvi ≤ 600 mikromola/l do 12. mjeseca, 7 bolesnika postiglo je taj prag do 24. mjeseca, a 8 bolesnika postiglo je taj prag do 36. mjeseca.
English: Manifestations included a combination of the following acute signs and symptoms: syncope, hypotension, hypoxia, dyspnoea, wheezing, chest discomfort/chest tightness, tachycardia, angioedema (swelling of face, lips, eyes, and tongue), flushing, rash, urticaria, pruritus, and gastrointestinal symptoms (vomiting, nausea, and diarrhoea).
Croatian: Manifestacije su obuhvaćale kombinaciju sljedećih akutnih znakova i simptoma: sinkopu, hipotenziju, hipoksiju, dispneju, piskanje, nelagodu/stezanje u prsima, tahikardiju, angioedem (oticanje lica, usana, očiju i jezika), nalete crvenila, osip, urtikariju, svrbež i gastrointestinalne simptome (povraćanje, mučnina i proljev).
English: PREPARING FOR INJECTION
Croatian: PRIPREMA ZA INJICIRANJE
English: Other medicines and Palynziq
Croatian: Drugi lijekovi i Palynziq
English: Follow these instructions carefully while you are using Palynziq.
Croatian: Pažljivo slijedite ove upute tijekom primjene lijeka Palynziq.
English: The most common cutaneous reactions (at least 5% of patients) reported were pruritus (37 patients; 13%), rash (33 patients; 12%), erythema (15 patients; 5%), and urticaria (15 patients; 5%).
Croatian: Najčešće zabilježene kožne reakcije (u najmanje 5% bolesnika) bile su pruritus (37 bolesnika; 13%), osip (33 bolesnika; 12%), eritem (15 bolesnika, 5%) i urtikarija (15 bolesnika, 5%).
English: • The goal is to reach a daily dose that lowers your blood phenylalanine levels to within the target range of 120 to 600 micromol/l and does not cause too many side effects.
Croatian: • Cilj je postići dnevnu dozu koja Vam snižava razinu fenilalanina u krvi na ciljni raspon od 120 do 600 mikromola/l i ne uzrokuje previše nuspojava.
English: The mean duration of arthralgia was 15 days and ranged 1 day to 936 days; 78% of arthralgia episodes had a duration of less than 14 days, and 1% of arthralgia episodes persisted at least 180 days.
Croatian: Srednja vrijednost trajanja artralgije bila je 15 dana u rasponu od 1 dana do 936 dana; 78% epizoda artralgije trajalo je manje od 14 dana, a 1% epizoda artralgije nastavilo se najmanje 180 dana.
English: Acute systemic hypersensitivity reactions were managed by administration of adrenaline (44%; 11/25 episodes), corticosteroids (56%; 14/25 episodes), antihistamines (56%; 14/25 episodes), and/or oxygen (8%; 2/25 episodes).
Croatian: Akutne sistemske reakcije preosjetljivosti liječene su primjenom adrenalina (44%; 11/25 epizoda), kortikosteroida (56%; 14/25 epizoda), antihistaminika (56%; 14/25 epizoda) i/ili kisika (8%; 2/25 epizoda).
English: 1 Blood phenylalanine level prior to initiating treatment with Palynziq.
Croatian: 1 Razina fenilalanina u krvi prije početka liječenja lijekom Palynziq.
English: The active substance is a covalent conjugate of the protein phenylalanine ammonia lyase (rAvPAL)* with NHS-methoxypolyethylene glycol (NHS-PEG).
Croatian: Djelatna tvar je kovalentni konjugat proteina fenilalanin-amonij-lijaze (rAvPAL)* sa NHS-metoksipolietilenglikolom (NHS-PEG).